Category Archives: G. BOTANICALS

Insufficient proof of efficacy for marijuana spray to permit sale in the UK

GW Pharmaceuticals was able to prove that Sativex, their marijuana oral spray product, was safe and reliably contained sufficient tetrahydrocannabinol. But proof of effectiveness was lacking, in the view of the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) Continue reading Insufficient proof of efficacy for marijuana spray to permit sale in the UK →

The Volcano alternative means of delivery of inhaled Cannabis sativa

An earlier study (reported here, discussed here) showed that the Volcano vaporization device is a reliable way to achieve lung concentrations of marijuana.

Now, researchers from the University of California and San Francisco General Hospital confirm that vaporization of cannabis is a safe and effective mode of delivery of tetrahydrocannabinol (THC). They think the device should be used in future studies of THC. Continue reading The Volcano alternative means of delivery of inhaled Cannabis sativa →

A critical review of herbals to treat anxiety and depression

In 2003, Professor Edzard Ernst writing on the Cochrane Collaboration website concluded, “Compared with placebo, kava extract is an effective symptomatic treatment for anxiety although, at present, the size of the effect seems small.” Continue reading A critical review of herbals to treat anxiety and depression →

Arnica: Not really par excellence

The website HealthWorld has an article on homeopathy that describes arnica (mountain daisy) as “par excellence” for the treatment of shock or trauma caused by any injury. Although the German Commission E Monograph lists herbal doses of arnica as approved for external use resulting from accidents, it questions arnica’s value in homeopathy, as discussed in this review.

Based on what we know, the frequent reference to arnica as “par excellence” is an overstatement. Continue reading Arnica: Not really par excellence →

Dissapointing recommendations to treat Alzheimer’s disease

These recommendations, from a group of experts, take a narrow view of Alzheimer’s disease. They focus on early detection and the use of existing prescription drugs.

That’s fine as far as it goes, but what about those with advanced Alzheimer’s? Why not develop a more comprehensive approach?

If I might quote Paul Harvey, “here’s the rest of the story.” Continue reading Dissapointing recommendations to treat Alzheimer’s disease →

Cannabinoid-receptor blocker will probably not be sold in the US

The New York Times reports, “The [FDA] advisory panel voted unanimously, 14 to 0, against recommending the drug [rimonabant, Acomplia, Zimulti], saying there was inadequate evidence of its safety. The FDA is not required to follow this advice, but it typically does.”

The report is interesting to this blog because rimonabant works by blocking cannabinoids receptors in the brain. Continue reading Cannabinoid-receptor blocker will probably not be sold in the US →

Black cohosh use during pregnancy

A survey of midwifes in the United States revealed that 45% used black cohosh to induce labor. The preparation is called “mother’s cordial? or “partus preparatus.” In addition to black cohosh, it contains squaw vine (Mitchella ripens), raspberry (Rubus idaeus), blue cohosh (Caulophyllum thalictroides), and false unicorn (Chamaelirium luteum).

What do we know about using black cohosh safely during pregnancy? Continue reading Black cohosh use during pregnancy →